Atlas Trials

Extension in AS: Sustainability of Benefits, Safety and Tolerability

Clinical trial NCT01863732 · COMPLETED

Trial details

NCT number
NCT01863732
Sponsor
Novartis Pharmaceuticals
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Spondylitis, Ankylosing
Start date
2013-11-06
Primary completion
2018-03-16
Enrollment
274

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.